Dyne Therapeutics, Inc. DYN
Regular-session close
After hours · Nov 13, 6:41 PM ET
- YTD
- -12.27%
- 1 year
- -8.87%
DYN free cash flow history
Free cash flow is operating cash flow minus capital expenditure outflow. It can be negative; it is not the same as earnings.
-423,917,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Capital expenditure here is net of asset disposals, so free cash flow can be higher than a figure that subtracts gross purchases.
Scroll the table to see all values →
| Fiscal period | Period end | Free cash flow | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | -423,917,000 | -129,172,000 | Not meaningful |
| FY 2024 | 2024-12-31 | -294,745,000 | -105,858,000 | Not meaningful |
| FY 2023 | 2023-12-31 | -188,887,000 | -32,175,000 | Not meaningful |
| FY 2022 | 2022-12-31 | -156,712,000 | -33,531,000 | Not meaningful |
| FY 2021 | 2021-12-31 | -123,181,000 | -75,512,000 | Not meaningful |
| FY 2020 | 2020-12-31 | -47,669,000 | -34,188,000 | Not meaningful |
| FY 2019 | 2019-12-31 | -13,481,000 | -9,183,000 | Not meaningful |
| FY 2018 | 2018-12-31 | -4,298,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-07-31T06:02:17.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.